Jenoptik Starts Digital Imaging Project with Syions

With Syions, Jenoptik is focusing its expertise in digital imaging on the fast growing biophotonics market. (Source: Matej Kastelic/Shutterstock)

Jenoptik signs a long-term agreement to develop and produce microscopy imaging instruments with a leading life science company based on the technology platform Jenoptik Syions. The scope of the agreement is anticipated to exceed 30 million euros for the coming years.

Jenoptik’s new solution Syions, a miniaturized modular diagnostic imaging platform, allows users to quickly and efficiently generate all types of image data from in-vitro diagnostics devices for use in scientific and clinical settings. Syions enables the quick and cost-effective implementation of applications in the areas of live cell imaging, flow cytometry, and molecular diagnostics.

The modular system solution combines Jenoptik modules such as LED illumination, optical elements, digital cameras, and auto-focus, as well as x/y scanners, electronics, and software, to enable efficient imaging solutions that provide the user with images of the highest quality and ensure easy integration into the software system environment of medical or laboratory devices. Moreover, with Jenoptik’s own modular software, work processes and more can be performed consistently and efficiently across various operating systems. For instance, with the help of Jenoptik’s Syions platform, the examination of cells or tissue samples can be automated quickly and reliably. Devices are decreasing in size while, at the same time, performance data is improving and reliability is increasing. Due to the standardization of the individual modules, these devices can now be produced cost-effective in smaller production runs.

The Syions system allows customers to take advantage of a range of imaging technologies and predefined modules to reduce time-to-market. Combining partially standardized optical, opto-mechanical, and electronic modules with powerful imaging and control software enables easy integration into existing instruments or completely new developments. The versatile, miniaturized platform can be adapted to a variety of bio-imaging applications to increase productivity in scientific and clinical laboratories.

“With Syions, Jenoptik is focusing its extensive expertise in digital imaging on the fast growing biophotonics market, and we are very excited about this partnership with a leading company in the global life sciences market,” said Dr. Stefan Traeger, president and CEO of Jenoptik. (Source: Jenoptik)

Link: Jenoptik AG, Jena, Germany

Speak Your Mind

*